CD8A and breast carcinoma: Moreover, NLRP3 knockout mice, orthotopically implanted with metastatic breast cancer cell line (E0771), upon treatment with OLT1177 compound, displayed reduced MDSCs, increased CD8+ T cells and NK populations within the microenvironment, increased immunotherapy efficacy, tumor reduction and improved survival [172].